PK

Prakash Kalubhai Thakor

Active Director Director DIN 11039943
DIN 11039943 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Prakash Kalubhai Thakor

Data last updated:

Prakash Kalubhai Thakor is a Director at Medistep Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Medistep Pharmaceuticals Private Limited reported revenue of ₹10.14 Cr (FY 2025).

DIN 11039943
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2025
Oldest Company Age 4 yrs
Largest company Medistep Pharmaceuticals Private Limited · ₹10.14 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20252022₹10.14 Cr (FY 2025)Active

Board colleagues of Prakash Kalubhai Thakor

Directorship timeline

Open interactive timeline →
Medistep Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prakash Kalubhai Thakor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Kalubhai Thakor

Prakash Kalubhai Thakor currently holds 1 directorship: Medistep Pharmaceuticals Private Limited (Director, since 31 Mar 2025, revenue ₹10.14 Cr (FY 2025)).

Prakash Kalubhai Thakor was first appointed on 31 Mar 2025 as Director at Medistep Pharmaceuticals Private Limited.

The current boards of Prakash Kalubhai Thakor's companies include Ankitbhai Anilbhai Desai (Medistep Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available